List of Excipients in API cetirizine hydrochloride and pseudoephedrine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cetirizine hydrochloride and pseudoephedrine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Johnson & Johnson Consumer Inc | ZYRTEC-D | cetirizine hydrochloride and pseudoephedrine hydrochloride | 50580-719 | CELLULOSE, MICROCRYSTALLINE | |
| Johnson & Johnson Consumer Inc | ZYRTEC-D | cetirizine hydrochloride and pseudoephedrine hydrochloride | 50580-719 | CROSCARMELLOSE SODIUM | |
| Johnson & Johnson Consumer Inc | ZYRTEC-D | cetirizine hydrochloride and pseudoephedrine hydrochloride | 50580-719 | HYPROMELLOSE | |
| Johnson & Johnson Consumer Inc | ZYRTEC-D | cetirizine hydrochloride and pseudoephedrine hydrochloride | 50580-719 | LACTOSE MONOHYDRATE | |
| Johnson & Johnson Consumer Inc | ZYRTEC-D | cetirizine hydrochloride and pseudoephedrine hydrochloride | 50580-719 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing cetirizine hydrochloride and pseudoephedrine hydrochloride
Detailed excipient profiles for cetirizine hydrochloride and pseudoephedrine hydrochloride
Excipient focus: AMMONIA
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing AMMONIA
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing BUTYL ALCOHOL
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing CROSCARMELLOSE SODIUM
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FERRIC OXIDE YELLOW
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | cetirizine hydrochloride and pseudoephedrine hydrochloride | 58602-703 |
| >Company | >Ingredient | >NDC |
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing FERROSOFERRIC OXIDE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYETHYL CELLULOSE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing HYDROXYETHYL CELLULOSE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing HYPROMELLOSE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing HYPROMELLOSES
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing ISOPROPYL ALCOHOL
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing LACTOSE MONOHYDRATE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing MAGNESIUM STEARATE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | cetirizine hydrochloride and pseudoephedrine hydrochloride | 50580-719 |
| Johnson & Johnson Consumer Inc | cetirizine hydrochloride and pseudoephedrine hydrochloride | 50580-728 |
| >Company | >Ingredient | >NDC |
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOLS
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cetirizine hydrochloride and pseudoephedrine hydrochloride | 54868-5879 |
| >Company | >Ingredient | >NDC |
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: PROPYLENE GLYCOL
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing PROPYLENE GLYCOL
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing SHELLAC
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing SILICON DIOXIDE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: STEARIC ACID
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing STEARIC ACID
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing STEARIC ACID
Excipient focus: TITANIUM DIOXIDE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants containing TITANIUM DIOXIDE
cetirizine hydrochloride and pseudoephedrine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aurohealth LLC | cetirizine hydrochloride and pseudoephedrine hydrochloride | 58602-703 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
